Strategic and people-centered clinical research leader with 22 years of experience delivering high-impact results in complex, multi-site clinical trials across biotech, pharmaceutical, and government sectors. Known for transforming operational efficiency, building cross-functional teams, and leading programs from concept through closeout in therapeutic areas such as infectious diseases, multiple sclerosis, TBI, asthma, and women’s health. Successfully managed IND and non-IND trials, registries, and cohort studies under FDA, ICH-GCP, and NIH guidelines, including a 17-year leadership tenure at Social & Scientific Systems (DLH). Trusted by sponsors and stakeholders to guide regulatory compliance, improve data integrity, and drive innovation in clinical operations.